REF: 2018-306
Subject: Intra-vitreal injections/implants
Request:
Dear Bolton NHS Foundation Trust,
Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between January to April 2018
If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].
| Lucentis (ranibizumab) Injections | Avastin (bevacizumab) Injections | Eylea (aflibercept) Injections | Illuvien (Fluocinolone) Impants | Ozudex (Dexamethasone) Implants | |
| Total | |||||
| Wet Age Related Macular Degeneration (wAMD) | |||||
| Diabetic Macular Oedema (DMO) | |||||
| Retinal Vein Occlusion – Central or Branch (CRVO or BRVO) | |||||
| Other eg mCNV |
Response:
| Lucentis (ranibizumab) Injections | Avastin (bevacizumab) Injections | Eylea (aflibercept) Injections | Illuvien (Fluocinolone) Impants | Ozudex (Dexamethasone) Implants | |
| Total | 858 | 0 | 1027 | 1 | 23 |
| We are unable to breakdown by disease. | |||||